Thursday, May 30, 2024
Canada’s Politics and Government News Source Since 1989
Thursday, May 30, 2024 | Latest Paper

Stéphanie Michaud

Dr. Stéphanie Michaud is the president and CEO of BioCanRx. She has more than 20 years of public, government and private sector experience in research and science & technology innovation policy and is a member of the Board of Directors of Research Canada.

Opinion | BY STéPHANIE MICHAUD | February 6, 2023
There is little doubt that cancer remains the most significant threat to the health and wealth of Canadians, with cancer deaths representing an average of 16.7 years of life lost for each diagnosed Canadian. All sources combined; Canada spends almost $500-million a year on cancer research all in the hope to unravel a path to the C-word—cure. Photograph courtesy of Pexels
Opinion | BY STéPHANIE MICHAUD | February 6, 2023
Opinion | BY STéPHANIE MICHAUD | February 6, 2023
There is little doubt that cancer remains the most significant threat to the health and wealth of Canadians, with cancer deaths representing an average of 16.7 years of life lost for each diagnosed Canadian. All sources combined; Canada spends almost $500-million a year on cancer research all in the hope to unravel a path to the C-word—cure. Photograph courtesy of Pexels